The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 29, 2019

Filed:

Mar. 02, 2015
Applicants:

National Cancer Center, Chuo-ku, JP;

Sekisui Medical Co., Ltd., Chuo-ku, JP;

Inventors:

Yae Kanai, Koto-ku, JP;

Eri Arai, Bunkyo-ku, JP;

Yuriko Nemoto, Chiba, JP;

Takuya Yotani, Ibaraki, JP;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6827 (2018.01); C12Q 1/6886 (2018.01); G01N 30/96 (2006.01); G01N 30/88 (2006.01); B01D 15/36 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); B01D 15/362 (2013.01); C12Q 1/6827 (2013.01); G01N 30/88 (2013.01); G01N 30/96 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/154 (2013.01); G01N 2030/8813 (2013.01);
Abstract

It is intended to provide a rapid, convenient, and highly accurate method for determining the prognosis of cancer. The present invention provides a method for determining the prognosis of a renal cell carcinoma patient, comprising: (1) treating genomic DNA prepared from a renal tissue of a subject with bisulfite; (2) amplifying the bisulfite-treated DNA by PCR; (3) subjecting the obtained PCR amplification product to ion exchange chromatography; (4) obtaining the retention time of a detection signal obtained by the chromatography; and (5) determining the renal cell carcinoma of the subject as having poor prognosis when the result of the step (4) is shorter than a retention time serving as a reference.


Find Patent Forward Citations

Loading…